In conclusion, the current study indicates that ELB exhibits a protective effect in rats with chronic alcoholic liver injury and gouty arthritis, possibly mediated by inhibiting TLR4/MyD88/NF-κB, NLRP3, and JAK2-STAT3 signaling pathways in both the hepatic and synovial tissues. Here, MYD88 is linked to gout.